Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Hypertension. 2012 Oct 29;60(6):1517–1523. doi: 10.1161/HYPERTENSIONAHA.112.203661

Figure 1.

Figure 1

Flow-mediated dilation (FMD, percent change in diameter) at baseline and after 2 and 7 days of fenofibrate or placebo. Values are mean±SE. *P<0.05 vs. baseline for same group.